Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
20
pubmed:dateCreated
2006-5-18
pubmed:abstractText
Amplification of the human epidermal growth factor receptor type 2 (HER2, also called HER2/neu) gene and overexpression of its product in breast-cancer cells may be associated with responsiveness to anthracycline-containing chemotherapy regimens.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
1533-4406
pubmed:author
pubmed:copyrightInfo
Copyright 2006 Massachusetts Medical Society.
pubmed:issnType
Electronic
pubmed:day
18
pubmed:volume
354
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2103-11
pubmed:dateRevised
2009-11-19
pubmed:meshHeading
pubmed-meshheading:16707747-Adult, pubmed-meshheading:16707747-Anthracyclines, pubmed-meshheading:16707747-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:16707747-Breast Neoplasms, pubmed-meshheading:16707747-Chemotherapy, Adjuvant, pubmed-meshheading:16707747-Cyclophosphamide, pubmed-meshheading:16707747-Epirubicin, pubmed-meshheading:16707747-Female, pubmed-meshheading:16707747-Fluorouracil, pubmed-meshheading:16707747-Gene Amplification, pubmed-meshheading:16707747-Gene Expression Regulation, Neoplastic, pubmed-meshheading:16707747-Genes, erbB-2, pubmed-meshheading:16707747-Humans, pubmed-meshheading:16707747-Methotrexate, pubmed-meshheading:16707747-Middle Aged, pubmed-meshheading:16707747-Premenopause, pubmed-meshheading:16707747-Prognosis, pubmed-meshheading:16707747-Receptor, erbB-2, pubmed-meshheading:16707747-Survival Analysis, pubmed-meshheading:16707747-Tumor Markers, Biological
pubmed:year
2006
pubmed:articleTitle
HER2 and responsiveness of breast cancer to adjuvant chemotherapy.
pubmed:affiliation
Toronto Sunnybrook Regional Cancer Centre and the University of Toronto, Toronto, ON, Canada. kathy.pritchard@sunnybrook.ca
pubmed:publicationType
Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't